{
    "nctId": "NCT05588973",
    "briefTitle": "Prevention of Radiodermatitis in Breast and Head and Neck Cancer Patients in Cyprus",
    "officialTitle": "Pilot Double-blind Randomized Controlled Clinical Trial for the Prevention of Radiodermatitis in Breast and Head and Neck Cancer Patients in Cyprus",
    "overallStatus": "NOT_YET_RECRUITING",
    "conditions": "Head and Neck Cancer, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 100,
    "primaryOutcomeMeasure": "Dermatological Quality of Life",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* over 18 years of age,\n* understand and be able to provide signed consent for the purpose of the research,\n* be diagnosed with breast or head and neck cancer,\n* undergo subfractionated radiotherapy of the breast in 15 sessions of a total dose of 40-42Gy, with or without the administration of a booster dose (boost),\n* to know the Greek or English language well\n* any wound should have healed after radiotherapy. The criteria will be evaluated by the medical staff of the hospital.\n\nExclusion Criteria:\n\n* those who do not meet the aforementioned inclusion criteria as well as:\n* those who suffer from inflammatory cancer,\n* those who have untreated wounds and/or other serious dermatological problems\n* those with severe/extensive burns\n* those who suffer from serious mental disorders (dementia, drug addiction, etc.) that require intensive treatment or monitoring,\n* those who have a sensitivity/allergy to any of the product's ingredients. The criteria will be evaluated by the medical staff of the hospital.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}